Somebody should give those guys a raise.
In the same week that NxStage Medical Inc. announced that company executives will not receive bonuses or raises after last year’s dismal stock performance, company officials said sales for the Lawrence-based dialysis maker jumped 115 percent in 2008.
NxStage, which makes dialysis equipment to treat end-stage renal failure, posted fourth-quarter sales of $35.7 million, up 19 percent over $29.8 million during the same period last year.
That helped the company narrow its net loss to $9.6 million for the quarter ended Dec. 31, 2008, compared with a net loss of $17.3 million during the fourth quarter of 2007.